Hogan Lovells guided Optinose, Inc. on the deal.Optinose, Inc. (NASDAQ:OPTN) has completed a registered direct offering of approximately US$55 million of its common stock and pre-funded…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Marco Zingaro
…
This content is for Standard 1 Year members only. LoginJoin Now